HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates

By Davis D.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 353-354

Elsevier

Access to resources Recommend Favorite

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite

Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A.   Honnen W.J.   Kayman S.C.   Trochev O.   Wu Z.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite

Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

By Lee S.A.   Orque R.   Escarpe P.A.   Peterson M.L.   Good J.W.   Zaharias E.M.   Berman P.W.   Sheppard H.W.   Shibata R.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 563-576

Elsevier

Access to resources Recommend Favorite

An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses

By Race E.   Frezza P.   Stephens D.M.   Davis D.   Polyanskaya N.   Cranage M.   Oxford J.S.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 54-60

Elsevier

Access to resources Recommend Favorite